Sangamo Therapeutics, Inc SEC filings SGMOQ

Sangamo Therapeutics, Inc has 1,000 filings in SEC EDGAR's recent list, going back to Feb 5, 2013. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Sangamo Therapeutics, Inc SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Oct 27, 2026 Oct 23, 2026
8-K Current report
Regulation FD disclosure
Oct 16, 2026 Oct 14, 2026
25-NSE Delisting notice Oct 7, 2026 —
8-K Current report
Bankruptcy, Acquisition or sale of assets
Sep 21, 2026 Sep 17, 2026
8-K Current report
Bankruptcy, Acquisition or sale of assets, Regulation FD disclosure
Sep 8, 2026 Sep 2, 2026
8-K Current report
Material agreement, Bankruptcy
Aug 28, 2026 Aug 25, 2026
NT 10-Q Filing Aug 17, 2026 Jun 30, 2026
8-K Current report
Other events
Aug 13, 2026 Aug 12, 2026
8-K Current report
Regulation FD disclosure
Aug 12, 2026 Aug 6, 2026
8-K Current report
Bankruptcy, Listing notice
Jul 20, 2026 Jul 14, 2026
8-K Current report
Auditor change, Other events
Jul 1, 2026 Jun 24, 2026
8-K/A Amended current report Jun 23, 2026 Jun 18, 2026
8-K Current report
Material agreement, Bankruptcy, New debt, Exit or restructuring costs
Jun 23, 2026 Jun 18, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
10-K/A Amended annual report Apr 30, 2026 Dec 31, 2025
8-K Current report
Listing notice
Apr 29, 2026 Apr 28, 2026
10-K Annual report Mar 30, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 30, 2026 Mar 30, 2026
8-K Current report
Material agreement, Unregistered share sale
Feb 4, 2026 Feb 3, 2026
424B5 Prospectus supplement Feb 4, 2026 —
8-K Current report
Other events
Feb 3, 2026 Feb 3, 2026
FWP Free writing prospectus Feb 3, 2026 —
8-K Current report
Results of operations, Officer or director change
Feb 3, 2026 Feb 2, 2026
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Listing notice
Oct 29, 2025 Oct 29, 2025
8-K Current report
Officer or director change
Sep 30, 2025 Sep 24, 2025
8-K Current report
Officer or director change
Sep 11, 2025 Sep 9, 2025
8-K Current report
Other events
Sep 4, 2025 Sep 4, 2025
S-8 Employee stock plan registration Aug 8, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Other events
Jun 24, 2025 Jun 24, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 16, 2025 Jun 12, 2025
424B5 Prospectus supplement May 13, 2025 —
8-K Current report
Other events
May 13, 2025 May 12, 2025
FWP Free writing prospectus May 13, 2025 —
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Listing notice
May 6, 2025 Apr 30, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 30, 2025 Jun 12, 2025
10-K Annual report Mar 17, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 17, 2025 Mar 17, 2025
8-K Current report
Other events
Feb 6, 2025 Feb 6, 2025
8-K Current report
Agreement ended
Dec 30, 2024 Dec 22, 2024
8-K Current report
Regulation FD disclosure, Other events
Dec 10, 2024 Dec 9, 2024
EFFECT Filing Nov 19, 2024 —
CORRESP Letter to the SEC Nov 18, 2024 —
UPLOAD Letter from the SEC Nov 18, 2024 —
S-8 Employee stock plan registration Nov 12, 2024 —
S-3 Shelf registration Nov 12, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Regulation FD disclosure
Oct 4, 2024 Oct 4, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
8-K Current report
Other events
Jul 24, 2024 Jul 24, 2024
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 5, 2024 Jun 4, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
8-K Current report
Listing notice
Apr 30, 2024 Apr 24, 2024
ARS Annual report to shareholders Apr 19, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 19, 2024 Jun 4, 2024
PRE 14A Preliminary proxy statement Apr 3, 2024 Jun 4, 2024
8-K Current report
Other events
Mar 25, 2024 Mar 21, 2024
424B5 Prospectus supplement Mar 25, 2024 —
8-K Current report
Results of operations
Mar 13, 2024 Mar 13, 2024
10-K Annual report Mar 13, 2024 Dec 31, 2023
8-K Current report
Other events
Feb 6, 2024 Feb 5, 2024
8-K Current report
Officer or director change
Jan 19, 2024 Jan 19, 2024
8-K Current report
Other events
Dec 13, 2023 Dec 11, 2023
8-K Current report
Other events
Nov 3, 2023 Nov 2, 2023
10-Q Quarterly report Nov 1, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 1, 2023 Nov 1, 2023
S-8 Employee stock plan registration Aug 8, 2023 —
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 2, 2023 Jun 1, 2023
10-Q Quarterly report May 8, 2023 Mar 31, 2023
8-K Current report
Results of operations, Exit or restructuring costs, Officer or director change
Apr 26, 2023 Apr 26, 2023
EFFECT Filing Apr 21, 2023 —
ARS Annual report to shareholders Apr 17, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 17, 2023 —
PRE 14A Preliminary proxy statement Apr 5, 2023 —
8-K Current report
Agreement ended
Mar 17, 2023 Mar 13, 2023
8-K Current report
Other events
Mar 14, 2023 Mar 13, 2023
8-K Current report
Other events
Mar 10, 2023 Mar 10, 2023
424B5 Prospectus supplement Mar 7, 2023 —
8-K Current report
Other events
Mar 7, 2023 Mar 7, 2023
8-K Current report
Regulation FD disclosure
Mar 2, 2023 Mar 2, 2023
S-8 Employee stock plan registration Feb 23, 2023 —
POS AM Filing Feb 23, 2023 —
10-K Annual report Feb 23, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 22, 2023 Feb 22, 2023
POSASR Filing Feb 22, 2023 —
424B5 Prospectus supplement Dec 23, 2022 —
8-K Current report
Material agreement
Dec 23, 2022 Dec 23, 2022
8-K Current report
Officer or director change, Bylaw or fiscal year change
Dec 19, 2022 Dec 15, 2022
8-K Current report
Other events
Dec 12, 2022 Dec 10, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Other events
Oct 12, 2022 Oct 12, 2022
8-K Current report
Other events
Sep 22, 2022 Sep 22, 2022
8-K Current report
Other events
Aug 30, 2022 Aug 30, 2022
8-K Current report
Officer or director change
Aug 9, 2022 Aug 8, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Officer or director change, Shareholder vote results
May 25, 2022 May 24, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 1, 2022 May 24, 2022
8-K Current report
Officer or director change
Apr 1, 2022 Mar 28, 2022
8-K Current report
Other events
Mar 28, 2022 Mar 22, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 24, 2022 Feb 24, 2022
8-K Current report
Other events
Feb 9, 2022 Feb 7, 2022
8-K Current report
Agreement ended
Jan 6, 2022 Dec 30, 2021
8-K Current report
Other events
Dec 13, 2021 Dec 12, 2021
8-K Current report
Officer or director change
Nov 22, 2021 Nov 17, 2021
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
8-K Current report
Material agreement, New debt
Oct 22, 2021 Oct 18, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
8-K Current report
Officer or director change
Jul 1, 2021 Jun 28, 2021
8-K Current report
Shareholder vote results
May 28, 2021 May 25, 2021
8-K/A Amended current report
Officer or director change
May 27, 2021 Mar 11, 2021
S-3ASR Automatic shelf registration May 5, 2021 —
10-Q Quarterly report May 4, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 4, 2021 May 4, 2021
DEF 14A Proxy statement Apr 2, 2021 May 25, 2021
8-K Current report
Officer or director change
Mar 17, 2021 Mar 11, 2021
10-K Annual report Feb 24, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 24, 2021 Feb 24, 2021
8-K Current report
Officer or director change
Jan 28, 2021 Jan 22, 2021
8-K Current report
Other events
Jan 14, 2021 Jan 14, 2021
8-K Current report
Officer or director change
Jan 6, 2021 Dec 31, 2020
8-K Current report
Bylaw or fiscal year change
Dec 15, 2020 Dec 14, 2020
8-K Current report
Regulation FD disclosure
Dec 7, 2020 Dec 7, 2020
10-Q Quarterly report Nov 4, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 4, 2020 Nov 4, 2020
S-8 Employee stock plan registration Oct 15, 2020 —
8-K Current report
Officer or director change
Sep 14, 2020 Sep 9, 2020
424B5 Prospectus supplement Aug 6, 2020 —
S-8 Employee stock plan registration Aug 5, 2020 —
10-Q Quarterly report Aug 5, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 5, 2020 Aug 5, 2020
8-K Current report
Material agreement
Jul 30, 2020 Jul 27, 2020
8-K Current report
Officer or director change
Jun 24, 2020 Jun 18, 2020
8-K/A Amended current report Jun 18, 2020 Jun 18, 2020
8-K Current report
Regulation FD disclosure
Jun 18, 2020 Jun 18, 2020
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
May 22, 2020 May 18, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 11, 2020 May 11, 2020
DEFA14A Additional proxy material May 8, 2020 —
8-K Current report
Officer or director change
Apr 17, 2020 Apr 13, 2020
DEF 14A Proxy statement Apr 2, 2020 May 18, 2020
PRE 14A Preliminary proxy statement Mar 23, 2020 May 18, 2020
10-K Annual report Feb 28, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 28, 2020 Feb 28, 2020
8-K Current report
Officer or director change
Feb 14, 2020 Feb 11, 2020
CT ORDER Filing Feb 3, 2020 —
8-K Current report
Material agreement
Dec 23, 2019 Dec 17, 2019
8-K Current report
Officer or director change
Nov 26, 2019 Nov 22, 2019
10-Q Quarterly report Nov 6, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 6, 2019 Nov 6, 2019
8-K Current report
Officer or director change
Nov 4, 2019 Oct 31, 2019
10-Q Quarterly report Aug 7, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 7, 2019 Aug 7, 2019
8-K Current report
Officer or director change, Shareholder vote results
Jun 14, 2019 Jun 10, 2019
8-K Current report
Officer or director change
May 14, 2019 May 13, 2019
10-Q Quarterly report May 8, 2019 Mar 31, 2019
8-K Current report
Results of operations, Officer or director change
May 8, 2019 May 3, 2019
DEFA14A Additional proxy material Apr 25, 2019 —
DEF 14A Proxy statement Apr 25, 2019 Jun 10, 2019
8-K Current report
Officer or director change
Apr 17, 2019 Apr 13, 2019
8-K Current report
Other events
Apr 4, 2019 Apr 4, 2019
424B5 Prospectus supplement Apr 4, 2019 —
424B5 Prospectus supplement Apr 3, 2019 —
8-K Current report
Other events
Apr 3, 2019 Apr 3, 2019
8-K Current report
Officer or director change
Mar 21, 2019 Mar 18, 2019
10-K Annual report Mar 1, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 28, 2019 Feb 28, 2019
CT ORDER Filing Feb 26, 2019 —
CT ORDER Filing Feb 26, 2019 —
CT ORDER Filing Feb 26, 2019 —
8-K Current report
Officer or director change
Feb 13, 2019 Feb 6, 2019
8-K/A Amended current report Jan 7, 2019 Nov 1, 2018
CT ORDER Filing Dec 3, 2018 —
10-Q Quarterly report Nov 8, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 8, 2018 Nov 8, 2018
8-K Current report
Acquisition or sale of assets
Nov 6, 2018 Nov 1, 2018
8-K Current report
Other events
Oct 1, 2018 Oct 1, 2018
10-Q Quarterly report Aug 8, 2018 Jun 30, 2018
8-K Current report
Results of operations
Aug 8, 2018 Aug 8, 2018
8-K Current report
Material agreement, Other events
Jul 23, 2018 Jul 20, 2018
8-K Current report
Officer or director change
Jun 28, 2018 Jun 26, 2018
CT ORDER Filing Jun 25, 2018 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
SGMOQ (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Richmond, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1001233
Former names
SANGAMO BIOSCIENCES INC (until Jan 6, 2017)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.